ENTPD5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.913400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.440200E-01
Normal-vs-Stage2
3.372600E-01
Normal-vs-Stage3
6.615600E-01
Normal-vs-Stage4
2.009000E-01
Stage1-vs-Stage2
9.433600E-01
Stage1-vs-Stage3
3.874600E-01
Stage1-vs-Stage4
2.053200E-01
Stage2-vs-Stage3
1.622570E-01
Stage2-vs-Stage4
2.860000E-01
Stage3-vs-Stage4
1.850430E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.107200E-01
Normal-vs-AfricanAmerican
2.974800E-01
Normal-vs-Asian
4.641200E-01
Caucasian-vs-AfricanAmerican
7.807400E-01
Caucasian-vs-Asian
4.829600E-01
AfricanAmerican-vs-Asian
3.588200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.685800E-01
Normal-vs-Female
4.315400E-01
Male-vs-Female
9.385200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.707000E-01
Normal-vs-Age(41-60Yrs)
2.883600E-01
Normal-vs-Age(61-80Yrs)
4.590400E-01
Normal-vs-Age(81-100Yrs)
1.894600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.055400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.112800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.255800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.468400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.646600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.785400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.382800E-01
Normal-vs-Daily Drinker
6.252800E-01
Normal-vs-Weekly Drinker
5.779600E-01
Normal-vs-Occasional Drinker
2.686400E-01
Normal-vs-Social Drinker
2.543800E-01
Non Drinker-vs-Daily Drinker
9.933600E-01
Non Drinker-vs-Weekly Drinker
8.286800E-01
Non Drinker-vs-Occasional Drinker
9.294200E-02
Non Drinker-vs-Social Drinker
9.469600E-01
Daily Drinker-vs-Weekly Drinker
8.979400E-01
Daily Drinker-vs-Occasional Drinker
1.320400E-01
Daily Drinker-vs-Social Drinker
9.595000E-01
Weekly Drinker-vs-Occasional Drinker
1.299810E-01
Weekly Drinker-vs-Social Drinker
8.156800E-01
Occasional Drinker-vs-Social Drinker
1.033770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.670400E-01
Normal-vs-Grade 2
2.600000E-01
Normal-vs-Grade 3
1.221610E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.949800E-01
Grade 1-vs-Grade 3
1.683170E-01
Grade 1-vs-Grade 4
3.670400E-01
Grade 2-vs-Grade 3
7.425800E-01
Grade 2-vs-Grade 4
2.600000E-01
Grade 3-vs-Grade 4
1.221610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.752800E-01
Normal-vs-NonDiabetic
4.129400E-01
Diabetic-vs-NonDiabetic
6.376000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.575000E-01
Normal-vs-NoPancreatitis
4.075400E-01
Pancreatitis-vs-NoPancreatitis
2.724900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.210400E-01
Normal-vs-N1
3.727400E-01
N0-vs-N1
7.204800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.821480E-03
Normal-vs-TP53-NonMutant
8.318200E-03
TP53-Mutant-vs-TP53-NonMutant
4.136000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
